Sonorheometry parameters during dabigatran reversal with idarucizumab for major bleeding
- 14 May 2025
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 392 (7) , 103605
Abstract
No abstract availableKeywords
Funding Information
- Centre Hospitalier Universitaire de Clermont-Ferrand
This publication has 20 references indexed in Scilit:
- Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?Thrombosis Research, 2024
- The Quantra System: System Description and Protocols for Measurements2023
- Point-of-Care Viscoelastic Hemostatic Assays in Cardiac Surgery Patients: Comparison of Thromboelastography 6S, Thromboelastometry Sigma, and QuantraJournal of Cardiothoracic and Vascular Anesthesia, 2023
- Comparison of the Quantra QPlus System With Thromboelastography in Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016Anaesthesia Critical Care & Pain Medicine, 2018
- International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral AnticoagulantsThrombosis and Haemostasis, 2018
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral AnticoagulantsJACC, 2017
- Idarucizumab for Dabigatran ReversalNew England Journal of Medicine, 2015
- Editor's Choice - Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III TrialsEuropean Journal of Vascular and Endovascular Surgery, 2014
- Triggers, targets and treatments for thrombosisNature, 2008